# Rahul Aggarwal

Source: https://onco.cc/people/rahul-aggarwal/  
OnCo record `rahul-aggarwal` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Prostate oncologist studying how tumours transform to escape hormone therapy and how to target them with radioligands.

## Summary

Rahul Aggarwal is Associate Director for Clinical Sciences at the UCSF Helen Diller Family Comprehensive Cancer Center. A medical oncologist specialising in prostate cancer, neuroendocrine prostate cancer and PSMA theranostics, he leads UCSF's early-phase and prostate cancer clinical research and defined treatment-emergent small-cell neuroendocrine prostate cancer, the way tumours transform to escape hormone therapy. His papers include a multi-institutional prospective study characterising that disease clinically and genomically, and a report on heterogeneous flare in PSMA PET tracer uptake after starting androgen pathway blockade. He leads PSMA radioligand and combination trials, including with lutetium-177 vipivotide tetraxetan.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Associate Director for Clinical Sciences, UCSF Helen Diller Family Comprehensive Cancer Center
- Specialisms: Prostate cancer; Neuroendocrine prostate cancer; PSMA theranostics

## Sources

- UCSF profile: https://profiles.ucsf.edu/search/?searchtype=people&searchfor=Rahul%20Aggarwal
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Aggarwal%20R%5BAuthor%5D
- Google Scholar: https://scholar.google.com/scholar?q=Rahul%20Aggarwal

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- targets: [Androgen receptor](https://onco.cc/targets/androgen-receptor/), [PSMA](https://onco.cc/targets/psma/)
- drugs: [Lutetium-177 vipivotide tetraxetan](https://onco.cc/drugs/pluvicto/)
- institutions: [UCSF Helen Diller Family Comprehensive Cancer Center](https://onco.cc/institutions/ucsf/)
- journals: [European Urology Oncology](https://onco.cc/journals/european-urology-oncology/)

---
JSON: https://onco.cc/api/v1/entities/rahul-aggarwal.json